Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Cholangiocarcinoma
Cholangiocarcinoma
NALIRICC Study of Nanoliposomal Irinotecan Combination Therapy in Metastatic BTC
Read More
Cholangiocarcinoma
Tislelizumab plus GemOx and Lenvatinib as a Conversion Therapy Regimen for Potentially Resectable BTCs
Read More
Cholangiocarcinoma
Health-Related QOL Study in Patients with CCA
Read More
Cholangiocarcinoma
Updated Analysis of the LUC2001 Study
Read More
Cholangiocarcinoma
Biliary Tract Cancers: Is Laparoscopic Liver Resection Adequate?
Read More
Cholangiocarcinoma
The Future of Neoadjuvant Chemotherapy for iCCA
Read More
Cholangiocarcinoma
Mayo Clinic Study Assessed Impact of Neoadjuvant Chemoradiation in Patients with Unresectable Perihilar CCA
Read More
Cholangiocarcinoma
Impact of Liver-Directed Radiation Therapy in Patients with Metastatic iCCA
Read More
Cholangiocarcinoma
Addition of Toripalimab to Standard Chemotherapy Gemcitabine plus S-1 for the First-Line Treatment of Advanced BTCs
Read More
Cholangiocarcinoma
Results from the STAMP Study: Adjuvant GemCis versus Capecitabine in Patients with Resected Lymph Node–Positive eCCA
Read More
1
2
3
4
5
6
7
Page 4 of 10
Results 31 - 40 of 99